In this episode, the TN team discuss three promising vaccine candidates being developed for COVID-19. We take a deep dive into the data from these vaccine trials to try and work out what successes can be celebrated and what unanswered questions still remain.
Read more from this podcast:
Vaccine 1: Moderna's mRNA-1273
Vaccine 2: Oxford University's ChAdOx1
Vaccine 3: CanSino Biologics' Adenovirus Type-5
Antigen vs Antibody – What Are the Differences?
A Vaccine 101
Exploring the Drug Development Process
Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
Create your
podcast in
minutes
It is Free